EU ‘Ready To Approve’ COVID-19 Vaccine On 23 December

Commission Negotiating Vaccine Contract Disclosure With Companies

European parliamentarians have defended the formal marketing authorization approach being taken by the EU, saying “safety is of the utmost importance” if there is to be trust in coronavirus vaccines.

Vaccine coronavirus covid-19 ncov 2019 virus infection research, test, analysis. Coronavirus SARS-CoV-2 treatment vaccine injection laboratory testing, immunization, prevention 3D medical illustration
The EU is expected to approve the COVID-19 vaccine next week • Source: Shutterstock

The European Commission says it is ready to approve the Pfizer/BioNTech COVID-19 vaccine on Wednesday 23 December if, as expected, the European Medicines Agency gives the vaccine the green light on Monday next week.

Addressing members of the European Parliament (MEPs) on 16 December, commission president Ursula von der Leyen said that “finally, within...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By 

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

  • EU Pharma Reform: What You Need to Know Now

     

    As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

  • New EU Approvals

    <p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography